Reborn Medical

Company Overview

Snapshot

Founded in July 2021 by Shir Kashi, Reborn Medical operates with 1–10 employees. The company has raised $2.02M across two funding rounds, with ICI Fund participating. In July 2024, Reborn Medical secured a grant from the Israel Innovation Authority.

Business overview

Reborn Medical is developing a portable and safe brain scanner utilizing ultrasound technology to create high-resolution 3D images comparable to a CT scan. This system is designed for use anytime, anywhere, with a primary focus on the Intensive Care Unit (ICU) market. The company aims to address challenges such as extended waiting times, transportation risks, and radiation exposure associated with traditional brain imaging. By implementing its scanner, Reborn Medical anticipates significant reductions in hospitalization days, infections, and treatment delays, projecting billions in annual cost savings for US hospitals. The company operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Diagnostics Devices, leveraging Simulation & Imaging, Ultrasound, and Artificial Intelligence technologies.

Company Intelligence Q&A

What is Reborn Medical's core technology?

Reborn Medical is developing a portable and safe brain scanner based on ultrasound technology, capable of producing high-resolution 3D images comparable to a CT scan.

When was Reborn Medical founded?

Reborn Medical was founded in July 2021.

Who is the founder of Reborn Medical?

Shir Kashi is the Founder & CEO of Reborn Medical.

What is Reborn Medical's primary target market?

Reborn Medical primarily focuses on the ICU market, aiming to address challenges related to brain scanning in critical care settings.

What was a recent significant funding event for Reborn Medical?

In July 2024, Reborn Medical secured a grant from the Israel Innovation Authority.